Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)

Shane, 2014, Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research, J Bone Miner Res, 29, 1, 10.1002/jbmr.1998 Yoneda, 2017, Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw, J Bone Miner Metab, 35, 6, 10.1007/s00774-016-0810-7 Ruggiero, 2014, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update, J Oral Maxillofac Surg, 72, 1938, 10.1016/j.joms.2014.04.031 Goldberg, 2016, Heterogeneity of osteoclast activity and bone turnover in different skeletal sites, Arch Oral Biol, 71, 134, 10.1016/j.archoralbio.2016.06.026 Kubek, 2010, Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible, Orthod Craniofac Res, 13, 214, 10.1111/j.1601-6343.2010.01497.x Allen, 2008, Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment, J Oral Maxillofac Surg, 66, 987, 10.1016/j.joms.2008.01.038 Win, 2014, Normal SUV values measured from NaF18- PET/CT bone scan studies, PLoS One, 9, 10.1371/journal.pone.0108429 Manolagas, 2000, Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis, Endocr Rev, 21, 115 Iwashita, 2000, Basic study of the measurement of bone mineral content of cortical and cancellous bone of the mandible by computed tomography, Dentomaxillofac Radiol, 29, 209, 10.1038/sj.dmfr.4600541 Wu, 2010, Densitometric and geometric measurement of the proximal femur in elderly women with and without osteoporotic vertebral fractures by volumetric quantitative multi-slice CT, J Bone Miner Metab, 28, 682, 10.1007/s00774-010-0174-3 Sigurdsson, 2006, Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK), Bone, 39, 644, 10.1016/j.bone.2006.03.020 Ritzel, 1997, The thickness of human vertebral cortical bone and its changes in aging and osteoporosis: a histomorphometric analysis of the complete spinal column from thirty-seven autopsy specimens, J Bone Miner Res, 12, 89, 10.1359/jbmr.1997.12.1.89 Silva, 1994, Direct and computed tomography thickness measurements of the human, lumbar vertebral shell and endplate, Bone, 15, 409, 10.1016/8756-3282(94)90817-6 Chen, 2002, Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases, J Clin Pharmacol, 42, 1228, 10.1177/009127002762491316 Ban, 2011, Determination of alendronate in low volumes of plasma by column-switching high-performance liquid chromatography method and its application to pharmacokinetic studies in human plasma, Arch Pharm Res, 34, 2079, 10.1007/s12272-011-1211-z Cole, 2016, Targeted delivery to bone and mineral deposits using bisphosphonate ligands, Adv Drug Deliv Rev, 99, 12, 10.1016/j.addr.2015.10.005 Lin, 1996, Bisphosphonates a review of their pharmacokinetic properties, Bone, 18, 75, 10.1016/8756-3282(95)00445-9 Kanishi, 1993, 99mTc-MDP accumulation mechanisms in bone, Oral Surg Oral Med Oral Pathol, 75, 239, 10.1016/0030-4220(93)90100-I Okamoto, 1995, Accumulation of technetium-99m methylene diphosphonate: Conditions affecting adsorption to hydroxyapatite, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 80, 115, 10.1016/S1079-2104(95)80027-1 Ristow, 2014, Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis, J Oral Maxillofac Surg, 72, 903, 10.1016/j.joms.2013.11.005 Ohbayashi, 2017, The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration, Odontology, 105, 382, 10.1007/s10266-016-0279-9 Martelli, 2017, Comparison of effects of zoledronic acid and clodronate on the bone structure: imaginological and histomorphometrical study in vivo, J Oral Pathol Med, 46, 632, 10.1111/jop.12546 Wen, 2011, Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate, Oral Dis, 17, 427, 10.1111/j.1601-0825.2010.01772.x Sato, 1991, Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure, J Clin Invest, 88, 2095, 10.1172/JCI115539 Won, 2010, Trabecular bone ratio of mandible using micro-computed tomography in Korean, J Craniofac Surg, 21, 920, 10.1097/SCS.0b013e3181d87a42 Kim, 2011, Variations in the trabecular bone ratio of the maxilla according to sex, age, and region using micro-computed tomography in Koreans, J Craniofac Surg, 22, 654, 10.1097/SCS.0b013e318207b77e Khan, 2015, Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus, J Bone Miner Res, 30, 3, 10.1002/jbmr.2405 Lipton, 2012, Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials, Eur J Cancer, 48, 3082, 10.1016/j.ejca.2012.08.002 Saad, 2012, Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases, Ann Oncol, 23, 1341, 10.1093/annonc/mdr435 Otto, 2010, Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism, J Oral Maxillofac Surg, 68, 2837, 10.1016/j.joms.2010.07.017